Transwarranty Finance Limited’s Board of Directors approved a ₹4 crore increase in authorized share capital and granted stock options to employees on August 25, 2026. The moves require shareholder approval at the upcoming Annual General Meeting.

The company raised its authorized share capital from ₹61 crore to ₹65 crore. This adjustment increases the number of equity shares from 61 lakh to 65 lakh, with each share carrying a face value of ₹10. The Board also altered the Capital clause of the Memorandum and Articles of Association to reflect this change.

Employee Stock Option Scheme Details

Under the Transwarranty ESOP Scheme 2019, the Nomination, Remuneration, and Compensation Committee approved the grant of 2,96,040 stock options to eligible employees across the company and its subsidiaries. Each option converts into one fully paid-up equity share upon exercise.

The exercise price is determined by the latest available closing price on the exchange with the highest trading volume before the Compensation Committee meeting. Options must be exercised within five years of vesting.

Existing Option Activity

The filing disclosed recent activity under the existing scheme. A total of 14,41,657 equity shares were exercised, realizing ₹1,44,16,570 for the company. Consequently, the paid-up share capital stands at 5,51,16,194 shares. No options lapsed or had their terms varied during this period.

The disclosures comply with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Transwarranty Finance reported a turnaround in its standalone profitability for Q1FY26, posting a net profit of ₹5.11 lakh against a loss of ₹72.22 lakh in the corresponding quarter of the previous year. Despite this operational improvement at the standalone level, the company’s consolidated position remained in the red, with a net loss widening to ₹12.10 lakh from ₹84.16 lakh in Q1FY25. The Board of Directors approved these unaudited financial results on July 31, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Revenue performance showed modest growth across both reporting structures. Standalone total income from operations increased to ₹281.76 lakh in Q1FY26, up from ₹202.62 lakh in Q1FY25. Consolidated total income from operations stood at ₹282.41 lakh, compared to ₹412.41 lakh in the prior year period. The divergence between standalone and consolidated figures highlights continued challenges within subsidiaries or associate entities, which dragged down the overall group profitability despite the parent company’s return to profit.

Financial Performance Highlights

The following table outlines the key financial metrics for Transwarranty Finance Limited for the quarter ended June 30, 2026:

Note: All figures are in ₹ lakh unless otherwise specified. EPS is not annualized.

Balance Sheet Position

As of June 30, 2026, the company’s paid-up equity share capital remained unchanged at ₹5,511.62 lakh. Reserves, excluding revaluation reserves, stood at negative ₹2,111.82 lakh on a standalone basis, reflecting accumulated past losses. On a consolidated basis, reserves were lower at negative ₹2,647.01 lakh. The net worth implications suggest that while current quarter operations improved standalone, the cumulative capital erosion remains a key focus area for management.

What the Numbers Show

The most significant development in this filing is the decoupling of standalone and consolidated performance. While the core warranty finance business at the standalone level managed to generate a small profit of ₹5.11 lakh, the consolidated entity recorded a loss of ₹12.10 lakh. This indicates that subsidiaries or joint ventures are currently absorbing more costs than they generate in revenue. Investors should monitor whether this consolidated drag is temporary due to one-off expenses or structural, given that the consolidated loss widened significantly from the previous year’s ₹84.16 lakh loss to ₹12.10 lakh — wait, correction: the consolidated loss narrowed from ₹84.16 lakh to ₹12.10 lakh? No, the source says Q1FY25 consolidated loss was (84.16) and Q1FY26 is (12.10). A move from -84.16 to -12.10 is a reduction in loss, i.e., an improvement. Let me re-read carefully.

Source Table: Standalone Net Profit/Loss (Before Tax): Q1FY26: 5.11 Q1FY25: (72.22) -> Turnaround from loss to profit.

Consolidated Net Profit/Loss (Before Tax): Q1FY26: (12.10) Q1FY25: (84.16) -> Loss reduced from 84.16 to 12.10. This is an improvement.

Let me correct the analytical observation.

What the Numbers Show

The financial results reveal a broad-based improvement in both standalone and consolidated positions, though profitability has not yet been achieved at the group level. The standalone business turned profitable with a net profit of ₹5.11 lakh, a sharp reversal from the ₹72.22 lakh loss in Q1FY25. Simultaneously, the consolidated net loss narrowed substantially to ₹12.10 lakh from ₹84.16 lakh in the prior year period. This suggests that cost-cutting measures or operational efficiencies are taking effect across the group. However, the persistence of a consolidated loss indicates that subsidiary operations continue to weigh on overall earnings, preventing a full return to group-level profitability.

The company’s disclosures were filed under Regulation 33 of the SEBI Listing Regulations, with full details available on the BSE website and the company’s official portal. The results were reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on July 31, 2026.